Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: Results of the FAB/LMB 96 international study

British Journal of Haematology

Volumn 141, Issue 6, 2008, Pages 840-847

  Gerrard, Mary ^a   Cairo, Mitchell S ^b   Weston, Claire ^c   Auperin, Anne ^d   Pinkerton, Ross ^e   Lambilliote, Anne ^f   Sposto, Richard ^g   McCarthy, Keith ^h   Lacombe, Marie José T ^d   Perkins, Sherrie L ⁱ   Patte, Catherine ^d  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

ⁱ UNIVERSITY OF UTAH   (United States)

Author keywords

B cell non Hodgkin lymphoma; Childhood; COPAD chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONSTIPATION; DRUG EFFICACY; DRUG FATALITY; FEMALE; FOLLOW UP; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PAIN; PRIORITY JOURNAL; STOMATITIS;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LYMPHOMA, B-CELL; MALE; METHOTREXATE; NEOPLASM STAGING; PREDNISONE; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VINCRISTINE;

EID: 44249088088     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07144.x     Document Type: Article

References (33)

1. Anderson, J.R., Wilson, J.F., Jenkin, D.T., Meadows, A.T., Kersey, J., Chilcote, R.R., Coccia, P., Exelby, P., Kushner, J., Siegel, S. Hammond, D. (1983) Childhood non-Hodgkin's lymphoma. Results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). New England Journal of Medicine, 308, 559 565.
2. Anderson, J.R., Jenkin, R.D., Wilson, J.F., Kjeldsberg, C.R., Sposto, R., Chilcote, R.R., Coccia, P.F., Exelby, P.R., Siegel, S., Meadows, A.T. Hammond, G.D. (1993) Long-term follow-up of patients treated with COMP or LSA2-L2 therapy for childhood non-Hodgkin's lymphoma, a report of CCG-551 from the children's cancer study group. Journal of Clinical Oncology, 11, 1024 1032.
3. Burke, G.A.A., Imeson, J., Hobson, R. Gerrard, M. (2003) Localised non-Hodgkin lymphoma with B-cell histology - cure without cyclophosphamide? A report of the United Kingdom Children's Cancer Study Group on studies NHL 8501 and NHL 9001 (1985-1996) British Journal of Haematology, 121, 586 591.
4. Cairo, M.S., Raetz, E., Lim, M.S., Davenport, V. Perkins, S.L. (2005) Childhood and adolescent non-Hodgkin lymphoma,new insights in biology and critical challenges for the future. Pediatric Blood and Cancer, 45, 753 769.
5. Cairo, M.S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, C.R., Michon, J., Weston, C., Perkins, S.L., Raphael, M., McCarthy, K. Patte, C., on behalf of the FAB LMB96 International Study Committee (2007) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood, 109, 2736 2743.
6. Castellucci, P., Zinzani, P., Pourdehnad, M., Alinari, L., Nanni, C., Farsad, M., Battista, G., Tani, M., Stefoni, V., Canini, R., Monetti, N., Rubello, D., Alavi, A., Franchi, R. Fanti, S. (2005) 18F-FDG-PET in malignant lymphoma, significance of positive findings. European Journal of Nuclear Medicine and Molecular Imaging, 32, 749 756.
7. Cox, D.R. Oakes, D. (1984) Analysis of Survival Data. Chapman and Hall, New York.
8. Dalle, J.H., Mechinaud, F., Michon, J., Gentet, J.C., de Lumley, L., Rubie, H., Schmitt, C. Patte, C. (2001) Testicular disease in childhood B-cell non-Hodgkin's lymphoma, the French Society of Pediatric Oncology experience. Journal of Clinical Oncology, 19, 2397 2403.
9. Harris, N., Jaffe, E., Stein, H., Banks, P.M., Chan, J.K.C., Cleary, M.L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K.C., Grogan, T.M., Isaacson, P.G., Knowles, D.M., Mason, D.Y., Muller-Hermelink, H.K., Pileri, S.A., Piris, M.A., Ralfkiaer, E. Warnke, R.A. (1994) A revised European-American classification of lymphoid neoplasms, a proposal from the international lymphoma study group. Blood, 84, 1361 1392.
10. Heerema, N.A., Bernheil, A., Lim, M.S., Look, A.T., Pasquialucci, L., Raetz, E., Sanger, W.G. Cairo, M.S. (2005) State of the art and future needs in cytogenetic/molecular genetics/arrays in childhood lymphoma, summary report of workshop at the First International Symposium on Childhood and adolescent non-Hodgkins lymphoma, April 9,2003. New York City NY. Pediatric Blood and Cancer, 45, 616 622.
11. Hernandez-Pampaloni, M., Takalkar, J., Yu, J.Q., Zhuang, H. Alavi, A. (2006) F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas. Pediatric Radiology, 36, 524 531.
12. Linassier, C., Desablens, B., Lefrancq, T., Le Prise, P.Y., Harousseau, J.L., Jacob, C., Gandhour, C., Haillot, O., Lucas, V., Leloup, R., Escoffre, M., Colombat, P. Tabuteau, S. (2002) GOELAMS study group. Stage I-IIIE primary non-Hodgkin's lymphoma of the testis, results of a prospective trial by the GOELAMS study group. Clinical Lymphoma, 3, 167 172.
13. Link, M.P., Donaldson, S.S., Berard, C.W., Shuster, J.J. Murphy, S.B. (1990) Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. New England Journal of Medicine, 322, 1169 1174.
14. Link, M.P., Shuster, J.J., Donaldson, S.S., Berard, C.W. Murphy, S.B. (1997) Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. New England Journal of Medicine, 337, 1259 1266.
15. Magrath, I. (1997) Limiting therapy for limited childhood non-Hodgkin's lymphoma. New England Journal of Medicine, 337, 1304.
16. Meadows, A.T., Sposto, R., Jenkin, R.D., Kersey, J.H., Chilcote, R.R., Siegel, S.E., Coccia, P.F., Rosenstock, J., Pringle, K.C. Stolar, C. (1989) Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children, a report from the children's cancer study group. Journal of Clinical Oncology, 1, 92 99.
17. Murphy, S.B. (1980) Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas, dissimilarities from lymphomas in adults. Seminars in Oncology, 7, 332 339.
18. Murphy, S.B., Hustu, H.O., Rivera, G. Berard, C.W. (1983) End results of treating children with localized non-Hodgkin's lymphomas with a combined modality approach of lessened intensity. Journal of Clinical Oncology, 1, 326 330.
19. Murphy, S.B., Fairclough, D.L., Hutchison, R.E. Berard, C.W. (1989) Non-Hodgkin's lymphomas of childhood, an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. Journal of Clinical Oncology, 7, 186 193.
20. Patte, C., Philip, T., Rodary, C., Zucker, J.M., Behrendt, H., Gentet, J.C., Lamagnere, J.P., Otten, J., Dufillot, D., Pein, F., Caillou, B. Lemerle, J. (1991) High survival rate in advanced stage B cell lymphoma and leukemias without CNS involvement with a short intensive polychemotherapy, results from the French Pediatric Oncology Society of a randomized trial of 216 children. Journal of Clinical Oncology, 9, 123 132.
21. Patte, C., Auperin, A., Michon, J., Behrendt, H., Leverger, G., Frappaz, D., Lutz, P., Coze, C., Perel, Y., Raphael, M. Terrier-Lacombe, M.J. (2001) The Societe Francaise d'Oncologie Pediatrique LMB89 protocol, highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 97, 3370 3379.
22. Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S.L., McCarthy, K., Cairo, M.S. for the FAB/LMB96 International Study Committee (2007) Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents; it is possible to reduce treatment for the early responding patients. Blood, 109, 2773 2780.
23. Pillon, M., Di Tullio, M.T., Garaventa, A., Cesaro, S., Putti, M.C., Favre, C., Lippi, A., Surico, G., Di Cataldo, A., D'Amore, E., Zanesco, L. Rosolen, A. (2004) Long-term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B-cell non-Hodgkin lymphoma (AIEOP LNH92). Cancer, 101, 385 394.
24. Pinkerton, C.R. (1999) The continuing challenge of treatment for non-Hodgkin's lymphoma in children. British Journal of Haematology, 107, 220 234.
25. Pinkerton, R. (2005) Continuing challenges in childhood non-Hodgkin's lymphoma. British Journal of Haematology, 130, 480 488.
26. Poirel, H., Heerema, N.A., Swansbury, J., Auperin, A., Launay, E., Sanger, W., Talley, P., Raphael, M., Perkins, S., McCarthy, K., Sposto, R., Weston, C., Gerrard, M., Cairo, M.S., Bernheim, A. Patte, C. (2005) In pediatric mature B-cell NHL, complex karyotype or del(13q) are linked prognostic factors in Burkitt lymphoma while 8q24/c-myc rearrangement is associated with a strong adverse effect in diffuse large B-cell lymphoma. Blood, 106, 541a.
27. Reiter, A., Schrappe, M., Parwaresch, R., Henze, G., Muller-Weihrich, S., Sauter, S., Sykora, K.W., Ludwig, W.D., Gadner, H. Riehm, H. (1995) Non-Hodgkin's lymphomas of childhood and adolescence. Results of a treatment stratified for biologic subtypes and stage. A report of the Berlin-Frankfurt- Munster Group. Journal of Clinical Oncology, 13, 359 372.
28. Reiter, A., Schrappe, M., Tiemann, M., Tiemann, M., Ludwig, W.D., Yakisan, E., Zimmermann, M., Mann, G., Chott, A., Ebell, W., Klingebiel, T., Graf, N., Kremens, B., Müller-Weihrich, S., Plüss, H.J., Zintl, F., Henze, G. Riehm, H. (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy, a report of the Berlin-Frankfurt-Munster Group trial NHL BFM 90. Blood, 10, 3294 3306.
29. Rothman, K.J. (1978) Estimation of confidence limits for the cumulative probability of survival in life table analysis. Journal of Chronic Diseases, 31, 557 560.
30. Sasai, K., Yamabe, H., Tsutsui, K., Dodo, Y., Ishigaki, T., Shibamoto, Y. Hiraoka, M. (1997) Primary testicular non-Hodgkin's lymphoma, a clinical study and review of the literature. American Journal of Clinical Oncology, 20, 59 62.
31. Seymour, J.F., Solomon, B., Wolf, M.M., Januscaewicz, E.H., Wirth, A. Prince, H.M. (2001) Primary large-cell non-Hodgkin's lymphoma of the testis, a retrospective analysis of patterns of failure and prognostic factors. Clinical Lymphoma, 2, 109 115.
32. Woessmann, W., Seidemann, K., Mann, G., Zimmermann, M., Burkhardt, B., Oschlies, I., Ludwig, W.D., Klingebiel, T., Graf, N., Gruhn, B., Juergens, H., Niggli, F., Parwaresch, R., Gadner, H., Riehm, H., Schrappe, M. Reiter, A. (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms, a report of the BFM Group Study NHL-BFM95. Blood, 105, 948 958.
33. Zouhair, A., Weber, D., Belkacemi, Y., Ketterer, N., Dietrich, P.Y., Villa, S., Scandolaro, L., Bieri, S., Syuder, G., Delacretaz, F., Girardet, C., Mirimanoff, R.O., Ozsahin, M. Rare Cancer Network (2002) Outcome and patterns of failure in testicular lymphoma, a multicenter rare cancer network study. International Journal of Radiation Oncology Biology, Physics, 52, 652 656.